Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 4Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Wound Infection 1Surgical Wound Infection 1Stomach Neoplasms 1Sarcopenia 1Postoperative Complications 1Polyps 1Phagocyte Bactericidal Dysfunction 1Obesity 1Malnutrition 1Liver Neoplasms 1Barrett Esophagus 1Adenomatous Polyposis Coli 1

Interventions

Adiposity 2Urine Specimen Collection 1Tirzepatide 1Therapeutics 1Sugammadex 1Stents 1Psychology, Positive 1Propofol 1Pancreaticoduodenectomy 1Methods 1Metformin 1Medical History Taking 1Mammography 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Gastrectomy 1Exercise 1Esophagectomy 1Docosahexaenoic Acids 1Diet, Healthy 1Colonoscopy 1Caloric Restriction 1Blood Specimen Collection 1Blood Pressure 1Biopsy 1Bariatric Surgery 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Docosahexaenoic Acids × Gastrointestinal × Clear all
NCT01733147 2022-01-11

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Mayo Clinic

Phase 4 Completed
60 enrolled 6 charts
GastrointestinalOther

Barrett Esophagus, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡